What's breaking now, across thousands of outlets.
AbbVie and Genmab said their T-cell engager Epkinly passed a late-stage trial in first-line diffuse large B-cell lymphoma, clearing the way for a potential market showdown with Roche’s antibody-drug conjugate Polivy. The companies tested Epkinly ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
As many as 21 dengue cases have been reported in the federal capital so far this year, according to the … Read More The post Islamabad Reports 21 Dengue Cases appeared first on ProPakistani .
The milestone marks a significant expansion of digital healthcare delivery in the country, with eSanjeevani enabling patients to access medical consultations remotely and helping bridge geographical…
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight-loss and glucose-lowering benefits, has also been shown…
Sensible Biotechnologies raised $47 million to scale VECTOR, its integrated platform pairing AI-enabled mRNA design with manufacturing of naturally modified mRNA in living cells, aiming to develop…
It was reported last week that a worker at an anti-plague institute in Siberia's Irkutsk region died of pneumonic plague.
The death of a lab worker at a plague research institute in Russia has sparked claims about a lab accident, hundreds of infections and international spread.
